Advanced HIV disease among newly diagnosed clients identified through community- and facility-based HIV testing services in Eswatini

Background Despite the Kingdom of Eswatini surpassing the UNAIDS 95–95-95 targets, the persistence of Advanced HIV Disease (AHD) remains a clinical concern. Advanced HIV Disease increases morbidity and mortality. This study evaluated the rate of AHD among newly diagnosed clients aged ≥15 identified through the community-based testing in comparison to the facility-based testing. Methods A cross-sectional study was conducted in two groups (community and facility) of individuals newly diagnosed with HIV using secondary program data (October 2022–September 2025) to identify clients with WHO clinical stages 3 and 4 or defining disease which represent advanced HIV disease with severe immunosuppression or with a CD4 count 0.05). In facility group, factors associated with AHD included increase in age (aOR: 1.03 [1.01–1.05]; p 0.05) associated with AHD in community-based testing setting. Delayed ART initiation (8–28 days) was associated with AHD in both groups, that is, community group (aOR: 3.2 [1.9–4.1]; p = 0.2) and facility group (aOR: 2.7 [2.1–3.3]; p < 0.001), reflecting the clinical complexity of stabilizing AHD prior to ART initiation. Conclusion Community testing did not demonstrate an advantage in early diagnosis of HIV in this study, but reached a younger, mobile population than facility testing. Hence community testing can be a complementary strategy for sub populations who often bypass facility-based care as well as used in addressing localized drivers of late presentation. Facility-based testing, meanwhile, remains essential for symptomatic late presenters and people returning to care

Bivariate analysis · Coinfection · Cross-sectional study · Disease · Immunosuppression · Logistic regression · Young adult · HIV Research and Treatment · HIV-related health complications and treatments · HIV/AIDS Research and Interventions

• Towards Universal Voluntary HIV Testing and Counselling

  Open Access•Amitabh B Suthar, Nathan Ford et al.•PLoS Medicine•2013

  Incluir item

• Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa

  Open Access•Monisha Sharma, Roger Ying et al.•Nature•2015

  Incluir item

• Future challenges for clinical care of an ageing population infected with HIV

  Open Access•Mikaela Smit, Kees Brinkman et al.•The Lancet Infectious Diseases•2015

  Incluir item

• Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa

  Open Access•Kwabena Asare, Lara Lewis et al.•BMJ Global Health•2025

  Incluir item

• Prevalence of and factors associated with late diagnosis of HIV in Malawi, Zambia, and Zimbabwe

  Open Access•Andreas D Haas, Elizabeth Radin et al.•PLOS Global Public Health•2022

  Incluir item

• Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa

  Open Access•Menard Chihana, Helena Huerga et al.•Global Health Action•2019

  Incluir item

• A scoping review on the role of masculine norms in men’s engagement in the HIV care continuum in sub-Saharan Africa

  Katelyn M Sileo, Rebecca Fielding-Miller et al.•AIDS Care•2019

  Incluir item

• Poor rates of linkage to HIV care and uptake of treatment after home-based HIV testing among newly diagnosed 15-to-49 year-old men and women in a high HIV prevalence setting in South Africa

  Brendan Maughan-Brown, Sean Beckett et al.•AIDS Care•2021

  Incluir item